SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037977
Filing Date
2023-08-03
Accepted
2023-08-03 16:12:01
Documents
104
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-20230630.htm   iXBRL 10-Q 5392721
2 EX-10.3 bbio-ex10_3.htm EX-10.3 59270
3 EX-10.4 bbio-ex10_4.htm EX-10.4 58215
4 EX-10.5 bbio-ex10_5.htm EX-10.5 76637
5 EX-10.6 bbio-ex10_6.htm EX-10.6 52268
6 EX-10.7 bbio-ex10_7.htm EX-10.7 44853
7 EX-10.8 bbio-ex10_8.htm EX-10.8 59523
8 EX-10.9 bbio-ex10_9.htm EX-10.9 54393
9 EX-31.1 bbio-ex31_1.htm EX-31.1 33195
10 EX-31.2 bbio-ex31_2.htm EX-31.2 33316
11 EX-32.1 bbio-ex32_1.htm EX-32.1 15657
12 EX-32.2 bbio-ex32_2.htm EX-32.2 15967
  Complete submission text file 0000950170-23-037977.txt   21320212

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20230630_lab.xml EX-101.LAB 868548
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20230630.xsd EX-101.SCH 128384
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20230630_cal.xml EX-101.CAL 87990
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20230630_def.xml EX-101.DEF 522863
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20230630_pre.xml EX-101.PRE 681300
98 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20230630_htm.xml XML 4742935
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 231140097
SIC: 2834 Pharmaceutical Preparations